mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.053 |
0.4 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.4 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |